Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohort.
Saved in:
| Title: | Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohort. |
|---|---|
| Authors: | Glienke M; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Himmelsbach R; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Zirngibl M; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Metzger P; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Institute of Medical Bioinformatics and Systems Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany., Kühn J; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Miething C; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Sigle A; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany., Gratzke C; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Nientiedt C; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Rassner M; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Becker H; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Duyster J; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Lassmann S; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Werner M; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Börries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany., Grabbert M; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Nov 27; Vol. 15, pp. 1688779. Date of Electronic Publication: 2025 Nov 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
